Loading...
Market
What will be the operational status of Sanofi's Beijing facility by the end of 2025?
2
Resolution / Starting Odds
Fully operational • 25%
Partially operational • 25%
Not operational • 25%
Other • 25%
Sanofi's operational updates or industry reports
Story
Sanofi to Invest €1 Billion ($1.05 Billion) in Fourth Beijing Insulin Production Base Amid China-EU Trade Tensions
Dec 2, 2024, 09:14 PM
Sanofi, the French pharmaceutical giant, has announced plans to invest approximately 1 billion euros (around $1.05 billion) to establish a new insulin production facility in Beijing. This investment represents Sanofi's largest single investment in China to date and marks a significant move amid ongoing trade tensions between China and the European Union. The new manufacturing base will be Sanofi's fourth production and supply site in the country. The announcement was made following a memorandum of understanding signed recently, highlighting the company's commitment to expanding its operations in the region.
View original story
Similar markets
Construction started • 25%
Construction completed • 25%
Production started • 25%
None of the above • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 500 • 25%
500 to 1000 • 25%
1000 to 1500 • 25%
More than 1500 • 25%
Yes • 50%
No • 50%
Project halted • 25%
Project delayed • 25%
Project unaffected • 25%
Project expedited • 25%
Increase by over 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant change • 25%
2025 • 25%
2026 • 25%
2027 • 25%
2028 • 25%